Relationship of p53 Overexpression on Cancers and Recognition by Anti-p53 T Cell Receptor-Transduced T Cells-Reference-Cited by-同舟云学术

Relationship of p53 Overexpression on Cancers and Recognition by Anti-p53 T Cell Receptor-Transduced T Cells

Published:2008-11 Issue:11 Volume:19 Page:1219-1231
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Theoret Marc R.¹²,Cohen Cyrille J.³,Nahvi Azam V.¹,Ngo Lien T.¹,Suri Kimberly B.¹,Powell Daniel J.⁴,Dudley Mark E.¹,Morgan Richard A.¹,Rosenberg Steven A.¹

Affiliation:

1. Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892.

2. Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892.

3. Laboratory of Tumor Immunology and Immunotherapy, Bar-Ilan University, Ramat Gan 52900, Israel.

4. Ovarian Cancer Research Center, University of Pennsylvania, Philadelphia, PA 19104.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2008.083

Reference59 articles.

1. HLA class I and II genotype of the NCI-60 cell lines

2. Immune responses to p53 in patients with cancer:enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites

3. Combination of p53 Cancer Vaccine with Chemotherapy in Patients with Extensive Stage Small Cell Lung Cancer

4. The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website

5. p53-specific CD8+ T-cell responses in individuals with cutaneous squamous cell carcinoma

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell fate regulation governed by p53: Friends or reversible foes in cancer therapy;Cancer Communications;2024-02-04

2. T cell receptor therapeutics: immunological targeting of the intracellular cancer proteome;Nature Reviews Drug Discovery;2023-10-27

3. Introduction to Tumor Ecosystem;Tumor Ecosystem;2023

4. Boosting Antitumor Immunity with an Expanded Neoepitope Landscape;Cancer Research;2022-07-29

5. Adoptive T-cell Immunotherapy: Perfecting Self-Defenses;Experientia Supplementum;2022